☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Chemocentryx
ChemoCentryx’s Tavneos (avacopan) Receives EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated Vasculitis
January 20, 2022
OncoOne Entered into an Agreement with GenScript ProBio for the Manufacturing of Monoclonal Antibody Therapies Targeting oxMIF
November 18, 2021
Load more...
Back to Home
